Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Director sold 4,198 shares at $3.16 ($13,266)
  2. 4 Open-market sale Director sold 4,198 shares at $3.16 ($13,266)
  3. 4 Open-market sale Director sold 5,100 shares at $3.19 ($16,269)
  4. 4 Grant or award Director acquired 10,200 shares (grant or award)
  5. 4 Grant or award Director acquired 10,200 shares (grant or award)
  6. 4 Grant or award Director acquired 10,200 shares (grant or award)
  7. 4 Grant or award Director acquired 10,200 shares (grant or award)
  8. 4 Grant or award Director acquired 10,200 shares (grant or award)
  9. 4 Grant or award Director acquired 10,200 shares (grant or award)
  10. 4 Grant or award Director acquired 10,200 shares (grant or award)
  11. 4 Open-market sale Director sold 21,267 shares at $3.61 ($76,774)
  12. 4 Open-market sale Chief R&D Officer sold 73,716 shares at $4.65 ($342,779)
  13. 4 Open-market sale Chief R&D Officer sold 10,560 shares at $4.76 ($50,266)
  14. 4 Open-market sale SVP & General Counsel sold 3,189 shares at $4.76 ($15,180)
  15. 4 Open-market sale SVP & Chief Accounting Officer sold 2,006 shares at $4.76 ($9,549)
  16. 4 Open-market sale President & CEO sold 13,759 shares at $4.76 ($65,493)
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 8-K Event Executive or director change

Page 17 of 100 · 1,982 filings